ImmunityBio (IBRX) Long-Term Investments (2014 - 2023)
ImmunityBio's Long-Term Investments came in at $891,000 for Q4 2023, up 6.1% from $840,000 a year earlier and up 9.1% from the prior quarter.
Powered by 
Analysis
ImmunityBio (IBRX) Long-Term Investments (2014 - 2023) Analysis & Trends
Going back to Q4 2014, ImmunityBio's Long-Term Investments data covers 34 quarters.
- Long-Term Investments carries a five-year compound annual growth rate of -36.3% (FY2018 to FY2023).
- Going back by year, Long-Term Investments was $840,000 in FY2022 (+2.2%), $822,000 in FY2021 (-89.5%), $7.85 million in FY2020 (-15.2%) and $9.25 million in FY2019 (+8.9%).
- The Q4 2023 figure represents the highest quarterly Long-Term Investments since Q2 2022.
- Year-over-year, Long-Term Investments increased in five of the last eight quarters, with an average decline of 0.7%.
- The fastest year-over-year change in Long-Term Investments over five years came in Q2 2022 (growth of 11.2%), and the weakest in Q3 2021 (a decline of 91.4%).
- Business Quant data shows IBRX's Long-Term Investments at $817,000 (Q3 2023), $841,000 (Q2 2023) and $820,000 (Q1 2023) in the three quarters before Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.01 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 387.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.60 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 63.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 268.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.45 Bn |
| 10 | ImmunityBio | 7.17 Bn | 5.86 Bn | 47.55 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 891,000.00 |
| Sep 30, 2023 | 817,000.00 |
| Jun 30, 2023 | 841,000.00 |
| Mar 31, 2023 | 820,000.00 |
| Dec 31, 2022 | 840,000.00 |
| Sep 30, 2022 | 811,000.00 |
| Jun 30, 2022 | 914,000.00 |
| Mar 31, 2022 | 865,000.00 |
| Dec 31, 2021 | 822,000.00 |
| Sep 30, 2021 | 802,000.00 |
| Jun 30, 2021 | 822,000.00 |
| Mar 31, 2021 | 1.00 Mn |
| Dec 31, 2020 | 7.85 Mn |
| Sep 30, 2020 | 9.30 Mn |
| Jun 30, 2020 | 9.30 Mn |
| Mar 31, 2020 | 9.25 Mn |
| Dec 31, 2019 | 9.25 Mn |
| Sep 30, 2019 | 9.25 Mn |
| Jun 30, 2019 | 9.25 Mn |
| Mar 31, 2019 | 9.25 Mn |
API Access
ImmunityBio Long-Term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-investments&ticker=IBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-investments", "ticker": "IBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-investments&ticker=IBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();